Themis Medicare Ltd Share Price

Q: What is the share price of Themis Medicare Ltd today?

Themis Medicare Ltd share price as on 22 Jan 2025 is ₹253.95

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: THEMISMED Small Cap ISIN: INE083B01024

As on 22 January 2025 at 18:34 IST

₹253.95

-3.85

(-1.49%)

Sell Buy

Over 1 Month

-2.16%

Over 6 Months

17.34%

Over 1 Year

21.80%

Over 3 Years

159.10%

Themis Medicare Ltd Summary

Close ₹ 253.95

Open ₹ 258.80

High ₹ 258.80

Low ₹ 242

Volume 96,321

Net Turnover (in ₹) ₹ 2,38,99,566.40

52Wk High ₹ 317

52Wk Low ₹ 180.55

52Wk High / Low

180.55

317

Themis Medicare Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 2,372.79

EPS (TTM) 4.09

Book Value (BV) 31.71

Div. Yield 0.19 %

P/E (TTM) 70.22

Price/Book Value 8.10

Delivery % 44.71 %

Face Value 1

Key Ratios

PE Ratio 81.41

PB Ratio 7.52

EV to Sales 5.48

PEG Ratio -0.86

ROA 6.23

ROE 9.59

Debt-Equity 0.36

Net Profit Margin 6.48

Operating Profit Margin 14.74

Themis Medicare Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	386.52	365.83	401.16	234.29	205.05
Total Expenses	351.88	306.93	317.23	202.44	187.08
Profit Before Tax	53.44	72.51	95.26	41.33	26.87
Profit After Tax	43.52	56.90	72.88	35.70	24.78
Operating Profit after Depreciation	44.01	68.46	92.70	44.57	30.85

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	168.37	162.20	144	133.10	116.31
Total Non Current Assets	273.25	249.43	213.62	185.67	169.42
Total Current Assets	293.17	264.53	214.16	185.47	180.49
TOTAL ASSETS	566.42	513.96	427.78	371.14	349.91
Total Shareholder's Fund	377.67	339.44	287.49	218.51	183.02

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	22.09	16.09	34.39	56.98	0.33
Net Cash used in Investing Activities	-15.95	-23.96	-15.59	-15.65	-5.47
Net Cash used in Financing Activities	-8.77	0.14	-17.55	-25.65	6.72

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	386.52	365.83	401.16	234.29	205.06
Total Expenses	351.85	306.92	317.22	202.04	187.05
Profit Before Tax	34.67	58.91	83.94	32.25	18
Profit After Tax	24.75	43.29	61.56	26.62	15.91
Operating Profit after Depreciation	44.04	68.47	92.71	44.96	30.88

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	168.36	162.20	144	133.10	116.31
Total Non Current Assets	195.52	190.49	168.32	151.69	144.90
Total Current Assets	294.44	265.80	215.42	186.72	181.28
TOTAL ASSETS	489.97	456.29	383.74	338.40	326.18
Total Shareholder's Fund	301.28	281.83	243.48	185.80	159.31

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	22.04	16.07	34.39	56.98	0.33
Net Cash used in Investing Activities	-15.96	-23.96	-15.58	-15.65	-5.46
Net Cash used in Financing Activities	-8.77	0.14	-17.55	-25.65	6.72

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	117.01	122.99	97.82	82.51	104.78
Total Expenses	99.88	93.81	88.52	74.45	92.38
Profit Before Tax	17.80	31.35	8.75	8.21	13.95
Profit After Tax	14.29	24.68	6.64	7.37	11.32
Operating Profit after Depreciation	22.69	36.12	13.97	13.99	19.06

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	99.59	106.08	75.52	82.51	104.78
Total Expenses	83.89	78.43	68.11	74.44	92.38
Profit Before Tax	13.81	25.91	5.58	2.85	9.73
Profit After Tax	9.87	18.71	3.09	2	7.10
Operating Profit after Depreciation	16.47	28.36	8.25	8.63	14.84

Themis Medicare Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 251.95

S2 246.10

S3 236.20

Pivot 261.85

R1 267.70

R2 277.60

R3 283.45

Moving Average

20 SMA 262

50 SMA 275.15

100 SMA 271.04

200 SMA 247.51

Themis Medicare Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Themis Medicare Ltd

₹0.5/Share

Announcement Date 12 Jul 2024

Record Date 15 Jul 2024

Div Yield 50%

AGM Date: 19 Sep 2022

Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2022, inter alia, has recommended dividend for Financial Year ended March 31, 2022 of Rs. 5.00/- (Rupees Five only) i.e. @ 50% per equity share having face value of Rs. 10/-, aggregating to Rs. 460.02 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the Annual Report of the Company for the financial year ended 31st March, 2022 along with the Notice convening the 52nd Annual General Meeting (AGM) to be held on Monday, September 19, 2022 at 12:00 Noon through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). We request you to kindly take the same on record. (As Per BSE Announcement Dated on 26.08.2022) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the gist of proceedings of the 52nd Annual General Meeting of the Company held on Monday, 19th September, 2022. Kindly take the above intimation on your record. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the shareholders at the 52nd Annual General meeting held on 19th September,2022 considered and approved the appointment of M/s.Krishaan & Co., Chartered Accountants (Firm Registration No. 001453 S), as Statutory Auditors of the Company in place of the Retiring Auditors to carry out the Statutory Audit of the Company for a term of 5 (five) consecutive years from the conclusion of 52nd Annual General Meeting . Details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular CIR/CFD/CMD/4/2OIS dated September 09, 2015 is attached herewith as Annexure I. We wish to inform you that the Second term of office of Mr. Hoshang Sinor (DIN: 0007 4905) as Independent Director of the Company, came to end after conclusion of the 52nd Annual General Meeting held on 19th September, 2022. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the shareholders at the 52nd Annual General Meeting held on 19th September,2022 considered and approved the adopted a New set of Articles of Association. (As Per BSE Announcement Dated on 20.09.2022) As per the requirement of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, given below are the details of the voting results of the 52nd Annual General Meeting (AGM) of the Company, held on Monday, 19th September, 2022 which commenced at 12.01 p.m and concluded at 12.40 p.m through Video Conferencing (''VC'')/Other Audio Visual Means (''OAVM'') as per the prescribed format under the said regulation. Further, consolidated Scrutinizer's Report on remote e-voting and e-voting at the AGM also enclosed herewith. Kindly consider this as compliance under Regulation 44(3) of the SEBI (LODR) Regulations, 2015. Themis Medicare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 21.09.2022)

AGM Date: 09 Sep 2023

The 53rd Annual General Meeting ('AGM') of the Company will be held on Saturday 09' September, 2023 af 12.00 Noon in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India. Please find attached our letter for intimating cessation of Independent Director due to completion tenure in the AGM held on 9th September 2023 (As Per BSE Announcement dated on 09.09.2023) Please find enclosed report of the Scrutinizer for the resolutions passed in the AGM by the members in the AGM held on 9th September, 2023 (As per BSE Announcement Dated on 11/09/2023)

AGM Date: 22 Jul 2024

1) Approval of the Financial Results for the FY 2023-24 2) Final Dividend for the FY 2023-24. Please find our Notice of 54th AGM and Annual Report for the Financial Year 2023-24 (As Per BSE Announcement dated on 25.06.2024) On completion of tenure of Mr. Hariharan Subramaniam ceases to be Independent Director of the Company after conclusion of the 54th AGM held on 22nd July 2024. (As Per BSE Announcement Dated on 22.07.2024)

Themis Medicare Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Themis Medicare Ltd	₹257	₹2,365.43
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Themis Medicare Ltd News

Themis Medicare to discuss results

On 25 October 2024

19 Oct 2024, 10:22 am

Themis Medicare to hold board meeting

On 26 July 2024

17 Jul 2024, 09:49 am

Board of Themis Medicare recommends final dividend

Of Rs 0.5 per share

15 May 2024, 10:44 am

Themis Medicare schedules AGM

On 22 July 2024

15 May 2024, 10:44 am

Themis Medicare announces board meeting date

On 14 May 2024

04 May 2024, 10:14 am

Themis Medicare Ltd Stock Analysis

Annual revenue for Themis Medicare Ltd increased by 5.66% to ₹386.52 crore in FY 2024 from ₹365.83 crore in FY 2023.
Annual Net Profit for Themis Medicare Ltd decreased by 42.84% to ₹24.75 crore in FY 2024 from ₹43.29 crore in FY 2023.
Promoter Shareholding in Themis Medicare Ltd remains unchanged by 0.00% in the most recent quarter, from 67.15% in September 2024 to 67.15% in December 2024.
Themis Medicare Ltd delivered a 1-year return of 21.80% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Themis Medicare Ltd share price moved down by 1.49% from its previous close of INR ₹257.80. The latest Themis Medicare Ltd share price is INR ₹253.95.
Themis Medicare Ltd share price today has been at a low of 242 and a high of 258.80. Over the past 52 weeks, the Themis Medicare Ltd share price has seen a low of 180.55 and a high of 317.